全文获取类型
收费全文 | 3466篇 |
免费 | 91篇 |
国内免费 | 26篇 |
出版年
2023年 | 5篇 |
2022年 | 29篇 |
2021年 | 49篇 |
2020年 | 17篇 |
2019年 | 8篇 |
2018年 | 11篇 |
2017年 | 19篇 |
2016年 | 255篇 |
2015年 | 962篇 |
2014年 | 1307篇 |
2013年 | 83篇 |
2012年 | 88篇 |
2011年 | 83篇 |
2010年 | 78篇 |
2009年 | 46篇 |
2008年 | 41篇 |
2007年 | 34篇 |
2006年 | 20篇 |
2005年 | 56篇 |
2004年 | 63篇 |
2003年 | 28篇 |
2002年 | 30篇 |
2001年 | 35篇 |
2000年 | 17篇 |
1999年 | 20篇 |
1998年 | 8篇 |
1997年 | 13篇 |
1996年 | 7篇 |
1995年 | 6篇 |
1994年 | 5篇 |
1993年 | 19篇 |
1992年 | 14篇 |
1991年 | 12篇 |
1990年 | 9篇 |
1989年 | 16篇 |
1988年 | 8篇 |
1987年 | 3篇 |
1986年 | 5篇 |
1985年 | 5篇 |
1984年 | 3篇 |
1973年 | 3篇 |
1966年 | 4篇 |
1964年 | 2篇 |
1960年 | 2篇 |
1957年 | 6篇 |
1956年 | 2篇 |
1955年 | 2篇 |
1954年 | 2篇 |
1943年 | 2篇 |
1925年 | 2篇 |
排序方式: 共有3583条查询结果,搜索用时 265 毫秒
161.
162.
163.
Li-Ting Ho Wei-Hsian Yin Shao-Yuan Chuang Wei-Kung Tseng Yen-Wen Wu I-Chang Hsieh Tsung-Hsien Lin Yi-Heng Li Lien-Chi Huang Kuo-Yang Wang Kwo-Chang Ueng Ching-Chang Fang Wen-Harn Pan Hung-I Yeh Chau-Chung Wu Jaw-Wen Chen Taiwanese Secondary Prevention for patients with AtheRosCLErotic disease Registry Investigators 《PloS one》2015,10(3)
Background
Epidemiological and clinical studies have clearly established the link between low-density lipoprotein cholesterol (LDL-C) and atherosclerosis-related cardiovascular consequences. Although it has been a common practice for physicians to prescribe lipid-lowering therapy for patients with dyslipidemia, the achievement rate is still not satisfied in Taiwan. Therefore, the determinants for achieving the LDL-C target needed to be clarified for better healthcare of the patients with dyslipidemia.Method
This registry-type prospective observational study enrolled the patients with cardiovascular diseases (coronary artery disease (CAD) and cerebrovascular disease (CVD)) from 18 medical centers across Taiwan, and clinically followed them for five years. At every clinical visit, vital signs, clinical endpoints, adverse events, concurrent medications and laboratory specimens were obtained as thoroughly as possible. The lipid profile (total cholesterol, high-density lipoprotein cholesterol, LDL-C, triglyceride), liver enzymes, and creatinine phosphokinase were evaluated at baseline, and every year thereafter. The cross sectional observational data was analyzed for this report.Result
Among the 3,486 registered patients, 54% had their LDL-C < 100 mg/dL. By univariate analysis, the patients achieving the LDL-C target were associated with older age, more male sex, taller height, lower blood pressure, more under lipid-lowering therapy, more smoking cessation, more history of CAD, DM, physical activity, but less history of CVD. The multivariate analysis showed statin therapy was the most significant independent determinant for achieving the treatment target, followed by age, history of CAD, diabetes, blood pressure, and sex. However, most patients were on regimens of very-low to low equipotent doses of statins.Conclusion
Although the lipid treatment guideline adherence is improving in recent years, only 54% of the patients with cardiovascular diseases have achieved their LDL-C target in Taiwan, and the most significant determinant for this was statin therapy. 相似文献164.
165.
166.
167.
Sanjiv M. Baxi Ruth M. Greenblatt Peter Bacchetti Chengshi Jin Audrey L. French Marla J. Keller Michael H. Augenbraun Stephen J. Gange Chenglong Liu Wendy J. Mack Monica Gandhi Women’s Interagency HIV Study 《PloS one》2015,10(6)
Effective antiretroviral (ARV) therapy depends on adequate drug exposure, yet methods to assess ARV exposure are limited. Concentrations of ARV in hair are the product of steady-state pharmacokinetics factors and longitudinal adherence. We investigated nevirapine (NVP) concentrations in hair as a predictor of treatment response in women receiving ARVs. In participants of the Women’s Interagency HIV Study, who reported NVP use for >1 month from 2003–2008, NVP concentrations in hair were measured via liquid-chromatography-tandem mass-spectrometry. The outcome was virologic suppression (plasma HIV RNA below assay threshold) at the time of hair sampling and the primary predictor was nevirapine concentration categorized into quartiles. We controlled for age, race/ethnicity, pre-treatment HIV RNA, CD4 cell count, and self-reported adherence over the 6-month visit interval (categorized ≤ 74%, 75%–94% or ≥ 95%). We also assessed the relation of NVP concentration with changes in hepatic transaminase levels via multivariate random intercept logistic regression and linear regression analyses. 271 women contributed 1089 person-visits to the analysis (median 3 of semi-annual visits). Viral suppression was least frequent in concentration quartile 1 (86/178 (48.3%)) and increased in higher quartiles (to 158/204 (77.5%) for quartile 4). The odds of viral suppression in the highest concentration quartile were 9.17 times (95% CI 3.2–26, P < 0.0001) those in the lowest. African-American race was associated with lower rates of virologic suppression independent of NVP hair concentration. NVP concentration was not significantly associated with patterns of serum transaminases. Concentration of NVP in hair was a strong independent predictor of virologic suppression in women taking NVP, stronger than self-reported adherence, but did not appear to be strongly predictive of hepatotoxicity. 相似文献
168.
169.
170.